Your browser doesn't support javascript.
loading
Payer budget impact of an artificial intelligence in vitro diagnostic to modify diabetic kidney disease progression.
Datar, Manasi; Burchenal, William; Donovan, Michael J; Coca, Steven G; Wang, Elaine; Goss, Thomas F.
Affiliation
  • Datar M; Boston Healthcare Associates Inc., Boston, MA, USA.
  • Burchenal W; Boston Healthcare Associates Inc., Boston, MA, USA.
  • Donovan MJ; Renalytix Inc., New York, NY, USA.
  • Coca SG; Department of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Wang E; Department of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Goss TF; Boston Healthcare Associates Inc., Boston, MA, USA.
J Med Econ ; 24(1): 972-982, 2021.
Article in En | MEDLINE | ID: mdl-34304681
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Nephropathies Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Nephropathies Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article